Acting on insulin
Tuesday, 11 November, 2008
A PhD student from the Garvan Institute in Sydney has discovered a novel action for insulin, describing a new role in glucose uptake.
Freddy Yip and colleagues from the Garvan’s diabetes and obesity research program have found that a member of the myosin motor protein family, 1c, undergoes increased phosphorylation in response to insulin.
Myo1c is thought to play a role in delivering the glucose transporter GLUT4 to the plasma membrane in fat cells.
For people with type 2 diabetes, the team believes there may be blockages in the signal between insulin and Myo1c, perhaps leading to insulin resistance.
The research is published in the November 5 issue of Cell Metabolism [doi:10.1016/j.cmet.2008.09.011].
$780m Sydney Biomedical Accelerator gains its founding Executive Director
Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...
Portable point-of-care test detects four common STIs in under an hour
Australian researchers have developed a portable point-of-care test that detects four common...
AusBiotech and Proto Axiom partner on investor-focused life sciences programs
AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...
